Skip to content

Clinical study of facial photoaging

Clinical study of facial photoaging

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017625
Enrollment
Unknown
Registered
2018-08-07
Start date
2018-07-10
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial photoaging

Interventions

first:Resolve 1064nm treatment of PicoWay laser equipment
second:Resolve 1064nm+ 532nm treatment for PicoWay laser equipment

Sponsors

Dermatology Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Healthy women over the age of 35 years; 2. Fitzpatrick skin type III-V; 3. accompanied by varying degrees of photoaging; 4. Be able and willing to follow all interviews, treatments, and evaluations, including photo shoots that may be used for publication and reporting; 5. Be able to understand and provide written informed consent; 6. Women of childbearing age require reliable contraceptive methods to be used at least 3 months prior to the start of the study recruitment.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or planned pregnancy during the study; 2. There are metal implants such as pacemakers in the body; 3. Photoallergy to the near-infrared wavelength region; 4. There is light-induced epilepsy; 5. Oral administration of photosensitizers such as isotretinoin within 8 weeks prior to the start of treatment or during the study; 6. Facial skin grinding or chemical exfoliation treatment within 3 months prior to the start of treatment or during the study; 7. There are active local or systemic infections, or open wounds in the treated area; 8. A history of keloid formation or poor wound healing in areas of previous skin lesions; 9. There are skin lupus; 10. There are active herpes simplex in the treated area; 11. There are multiple dysplasia in the treatment area; 12. There are any forms of active malignancy during recruitment or during the study; 13. There are obvious systemic diseases or obvious areas of treatment in the treatment area; 14. Participate in other equipment or drug studies within 6 months prior to the start of treatment or during the study; 15. Evidence of mental or intellectual abnormalities, prisoners, or any active drug or alcohol dependence.

Design outcomes

Primary

MeasureTime frame
global photoaging scale;

Secondary

MeasureTime frame
subjective satisfaction ;

Countries

China

Contacts

Public ContactTong Lin

Dermatology Hospital, Chinese Academy of Medical Sciences

ddlin@hotmail.com+86 13951902258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026